| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,,
Departments of
*
Laboratory Medicine,
Medicine, and
Epidemiology, University of Washington, and
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and
¶ Corixa Corp., Seattle, Washington 98104
During the course of investigating T cell responses to HSV among volunteers entering trials of investigational genital herpes vaccines, 6 of the 24 immunocompetent subjects with no prior history of oral/labial or genital herpes possessed HSV-specific T cell immunity but, by multiple determinants of even the most sensitive serological assays, remained seronegative to HSV-1 and -2. Of these six immune seronegative (IS; HSV-seronegative with HSV-specific T cell responses) subjects, two had transient HSV-specific T cell responses, while four had CD4+ and CD8+ T cell responses directed at HSV that persisted for up to 4 years. CD4+ T cell clones were isolated that recognized and had high binding affinities to epitopes in HSV-2 tegument proteins. All six IS subjects had potential sexual exposure to an HSV-2-infected sexual partner. Oral and genital mucosal secretions were sampled and tested for the presence of infectious HSV and HSV DNA. No evidence of HSV was detected in >1500 samples obtained from these IS subjects. The identification of persistent T cell responses to HSV in seronegative subjects is a novel finding in the herpesvirus field and suggests either undetected infection or acquired immunity in the absence of infection. Understanding the basis of these acquired immune responses may be critical in developing effective vaccines for genital herpes.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  L. Jing, T. M. Chong, B. Byrd, C. L. McClurkan, J. Huang, B. T. Story, K. M. Dunkley, L. Aldaz-Carroll, R. J. Eisenberg, G. H. Cohen, et al. Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus J. Immunol., May 15, 2007; 178(10): 6374 - 6386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hosken, P. McGowan, A. Meier, D. M. Koelle, P. Sleath, F. Wagener, M. Elliott, K. Grabstein, C. Posavad, and L. Corey Diversity of the CD8+ T-Cell Response to Herpes Simplex Virus Type 2 Proteins among Persons with Genital Herpes. J. Virol., June 1, 2006; 80(11): 5509 - 5515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jing, T. M. Chong, C. L. McClurkan, J. Huang, B. T. Story, and D. M. Koelle Diversity in the Acute CD8 T Cell Response to Vaccinia Virus in Humans J. Immunol., December 1, 2005; 175(11): 7550 - 7559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wald, A. G.M. Langenberg, E. Krantz, J. M. Douglas Jr, H. H. Handsfield, R. P. DiCarlo, A. A. Adimora, A. E. Izu, R. A. Morrow, and L. Corey The Relationship between Condom Use and Herpes Simplex Virus Acquisition Ann Intern Med, November 15, 2005; 143(10): 707 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Davies, M. C. Vallejo, K. T. Shannon, A. J. Amortegui, and S. Ramanathan Oral Herpes Simplex Reactivation After Intrathecal Morphine: A Prospective Randomized Trial in an Obstetric Population Anesth. Analg., May 1, 2005; 100(5): 1472 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Kaufman, A. M. Azcuy, E. D. Varnell, G. D. Sloop, H. W. Thompson, and J. M. Hill HSV-1 DNA in Tears and Saliva of Normal Adults Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
